Development and Validation of a Risk Prediction Model for Second Primary Lung Cancer

BACKGROUND: With advancing therapeutics, lung cancer (LC) survivors are rapidly increasing in number. Although mounting evidence suggests LC survivors have high risk of second primary lung cancer (SPLC), there is no validated prediction model available for clinical use to identify high-risk LC survi...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Eunji, Sanyal, Nilotpal, Ding, Victoria Y, Gardner, Rebecca M, Aredo, Jacqueline V, Lee, Justin, Wu, Julie T, Hickey, Thomas P, Barrett, Brian, Riley, Thomas L, Wilkens, Lynne R, Leung, Ann N, Le Marchand, Loïc, Tammemägi, Martin C, Hung, Rayjean J, Amos, Christopher I, Freedman, Neal D, Cheng, Iona, Wakelee, Heather A, Han, Summer S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755509/
https://www.ncbi.nlm.nih.gov/pubmed/34255071
http://dx.doi.org/10.1093/jnci/djab138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8755509/
https://www.ncbi.nlm.nih.gov/pubmed/34255071
http://dx.doi.org/10.1093/jnci/djab138

Ejemplares similares